• Home
  • Cardiovascular
  • 2003 European Society of Hypertension - European Society of by Sverre Erik Kjeldsen

2003 European Society of Hypertension - European Society of by Sverre Erik Kjeldsen

By Sverre Erik Kjeldsen

High blood pressure, hypercholesterolemia and smoking current the #1 hazard elements for heart problems and demise. therefore cardiologists play a key position within the care of hypertensive sufferers and as educators within the box. This targeted factor of "Heart Drug" good points joint guidance for the detection and therapy of high blood pressure, built by means of the ecu Society of high blood pressure and the ecu Society of Cardiology. in accordance with the 1999 overseas Society of Hypertension/World wellbeing and fitness association directions and recommended by means of the overseas Society of high blood pressure, those new guidance combine detection and remedy of alternative very important possibility components, similar to diabetes, and, for the 1st time, comprise the detection of aim organ harm like left ventricular hypertrophy, arterial plaque, microalbuminuria or somewhat increased serum creatinine. the ideas extra spotlight a couple of medicines for the remedy of high blood pressure.

Show description

Read Online or Download 2003 European Society of Hypertension - European Society of Cardiology Guidelines for the Management of Arterial Hypertension PDF

Similar cardiovascular books

Atherosclerosis: Experimental Methods and Protocols

Kid's health center study origin, Cincinnati, OH. allows biomedical researchers to choose these optimized options that could be used to review the advance, development, and remedy of atherosclerotic lesions. define structure.

ABC of Hypertension

Hypertension is a typical continual scientific challenge encountered in basic care, but it really is ordinarily less than clinically determined. ABC of high blood pressure is a protracted confirmed, useful advisor to the research, remedy and administration of hypertensive sufferers. This 6th edition:Provides functional assistance on size of blood strain and the research and administration of hypertensive patientsExplains new advancements in size and automatic dimension of blood strain andUpdates assurance on therapy of the aged and explains of the consequences of contemporary trialsIncorporates present British high blood pressure Society and great instructions

Molecular and Multimodality Imaging in Cardiovascular Disease

This ebook presents the main up to date assurance of the mixed use of imaging modalities so one can gather vital practical and morphological details on heart problems and increase illness detection. the hot advancements in PET/MRI, cardiac CT, PET/CT and SPECT/CT and their effect on scientific perform are defined and distinctive cognizance can be dedicated to imaging parameters and protocols to be used in perform and learn.

Extra resources for 2003 European Society of Hypertension - European Society of Cardiology Guidelines for the Management of Arterial Hypertension

Sample text

How to evaluate the benefits. Am J Cardiol 1997;79:3– 8. 35 Franklin SS, Wong ND: Cardiovascular risk evaluation: an inexact science. J Hypertens 2002;20:2127–2130. 36 Reaven G: Metabolic Syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation 2002;106: 286–288. 37 Zanchetti A, Ruilope LM: Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials? J Hypertens 2002;20:2099– 2110. RV 38 Zanchetti A, Hansson L, Dahlof B, Elmfeldt D, Kjeldsen S, Kolloch R, et al: Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study.

Hypertensive patients with type 2 diabetes, on the other hand, benefit from intensive blood glucose control in terms of both macro- and microvascular complications [313]. A direct association exists between these complications and the mean HbA1c, with no indication of a threshold of HbA1c values below which the risk no longer decreases. 2 mmol/l for plasma preprandial glucose concentrations (average of several measurements), and at less than 7% for HbA1c [315]. European Society of HypertensionEuropean Society of Cardiology E.

Am J Cardiol 1997;79:3– 8. 35 Franklin SS, Wong ND: Cardiovascular risk evaluation: an inexact science. J Hypertens 2002;20:2127–2130. 36 Reaven G: Metabolic Syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation 2002;106: 286–288. 37 Zanchetti A, Ruilope LM: Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials? J Hypertens 2002;20:2099– 2110. RV 38 Zanchetti A, Hansson L, Dahlof B, Elmfeldt D, Kjeldsen S, Kolloch R, et al: Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study.

Download PDF sample

Rated 4.35 of 5 – based on 23 votes